Standard BioTools Inc. Common Stock (LAB) is a publicly traded Healthcare sector company. As of November 16, 2026, LAB trades at $0.62 with a market cap of $279.27M and a P/E ratio of -3.60. LAB moved -12.34% today. Year to date, LAB is -51.50%; over the trailing twelve months it is -50.32%. Its 52-week range spans $0.59 to $1.72. Rallies surfaces LAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for LAB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.62 |
| Market Cap | $279.27M |
| P/E Ratio | -3.60 |
| EPS | $-0.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.72 |
| 52-Week Low | $0.59 |
| Volume | 595.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $85.33M |
| Net Income | $-74.90M |
| Gross Margin | 49.86% |
LAB analyst coverage data. Average price target: $0.00.